Short answer · Medically reviewed summary · Last updated: 2026-05-08
GLUT1 deficiency, also known as De Vivo disease, was first identified in 1991 when researchers discovered that a defect in the SLC2A1 gene prevents glucose from crossing the blood-brain barrier. This breakthrough transformed the diagnosis of unexplained seizures and movement disorders, establishing the ketogenic diet as the gold-standard life-saving intervention for patients. When was GLUT1 deficiency first described? In 1991, Dr.
What is the history of GLUT1 deficiency?
History of GLUT1 deficiency: when and how it was discovered, and the milestones in research since, medically reviewed.
GLUT1 deficiency, also known as De Vivo disease, was first identified in 1991 when researchers discovered that a defect in the SLC2A1 gene prevents glucose from crossing the blood-brain barrier. This breakthrough transformed the diagnosis of unexplained seizures and movement disorders, establishing the ketogenic diet as the gold-standard life-saving intervention for patients.
When was GLUT1 deficiency first described?
In 1991, Dr. Darryl De Vivo and his colleagues at Columbia University published a landmark paper in the New England Journal of Medicine describing two children with seizures, developmental delay, and low cerebrospinal fluid (CSF) glucose levels. Before this discovery, these patients were often misdiagnosed with cerebral palsy or intractable epilepsy because their blood sugar levels appeared normal, while their brain glucose remained critically low.
How has our understanding of GLUT1 deficiency evolved?
Modern genetics has revolutionized the field by shifting the focus from clinical symptoms to molecular confirmation. We now know that GLUT1 deficiency is caused by mutations in the SLC2A1 gene. Advancements in technology have allowed researchers to identify a broader spectrum of the condition, including milder forms that may present only as paroxysmal exercise-induced dyskinesia (movement disorders) rather than classic epilepsy.
What are the major milestones in the history of GLUT1 deficiency?
- 1991: First clinical description of the syndrome by Dr. De Vivo.
- 1994: Identification of the SLC2A1 gene as the underlying cause.
- Early 2000s: Recognition that GLUT1 deficiency can present with diverse symptoms, including ataxia and cognitive impairment, even without seizures.
- Present: Ongoing exploration of pharmacological therapies to augment glucose transport or provide alternative fuel sources for the brain.
How has patient advocacy changed the landscape?
The history of GLUT1 deficiency is deeply tied to the rise of patient advocacy groups like the Glut1 Deficiency Foundation. By connecting families, these organizations have accelerated research and helped the 30 members of our DiseaseMaps.org community share experiences that inform clinical understanding. Today, awareness initiatives ensure that GLUT1 deficiency is considered earlier in the diagnostic process for children with unexplained neurological symptoms.
Next steps
- Consult a metabolic specialist or pediatric neurologist if you suspect GLUT1 deficiency.
- Request a lumbar puncture to measure CSF glucose levels, the historical and clinical gold standard for diagnosis.
- Connect with the GLUT1 deficiency community on DiseaseMaps.org to share insights and support.
Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment.
References
- NIH Genetic and Rare Diseases Information Center (GARD): SLC2A1 deficiency syndrome.
- Orphanet: Glucose transporter type 1 deficiency syndrome.
- OMIM (Online Mendelian Inheritance in Man): Entry #606777.
- Glut1 Deficiency Foundation: History and Research Initiatives.
